Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines

GSK•Philadelphia, PA

About The Position

Robust health outcomes data is necessary to support launch optimization, reimbursement and maintain market position in today’s healthcare environment. Evidence must be developed throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. We need to engage with our customers to understand how they define value and to effectively collaborate with them to ensure we are generating evidence that that is impactful for payers, health systems, providers, and patients. The role of Senior Director, Global Real-World Evidence & Health Outcomes Research (GRWE& HO) Lead is critical to achieving this ambition by ensuring that each medicine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing. The role is essential for the alignment of evidence with the requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use and commercial success. The role will be a key member of the Global Real-World Evidence & Health Outcomes Research Specialty LT and other relevant matrix leadership teams. The Senior Director, Global Real-World Evidence & Health Outcomes Research Lead will be accountable for ensuring team members engage closely with medical and matrix stakeholders and partner effectively in data generation plan (DGP) planning, design, execution, translation, and dissemination for the specialty asset.

Requirements

PhD, PharmD or equivalent level qualification in health outcomes, patient reported outcomes, health economics, epidemiology, pharmacy, health, or life sciences.
5+ years working in global pharmaceuticals in a leadership role with line management experience.
Strong business acumen and ability to translate customer needs into actionable data generation plan.
Methods expertise to guide and lead team in delivering robust payer evidence deliverables and credibility to engage meaningfully with external experts & leaders in the field.
Knowledge of the diversity and complexity of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and in local markets.
Understanding of how health economics, health outcomes, comparative effectiveness research, PRO research and the use of PRO instruments can be applied at local decision-making levels, including support of clinical practice.
Deep knowledge and strong communication skills are critical for interpreting and translating complex concepts and results effectively to a variety of audiences to impact decision making.
Deep knowledge of drug development and therapy area.
Strong matrix leadership and stakeholder management skills, with the ability to work independently and build credibility across the enterprise.
Experience across product lifecycles.
Experience leading a complex portfolio of projects, stakeholders, and other analytic staff in a senior role.

Nice To Haves

Advanced scientific or business degree specialized in Health Outcomes or similar.
Experience in above country and in country roles.
Experience in the hepatology therapeutic area.
Experience supporting assets in complex competitor landscapes.
Direct Payer experience.
Launch experience.
Portfolio of high value publications and/or scientific promotions.

Responsibilities

Provide leadership, management, and development of Data Generation book of work.
Partner effectively with matrix stakeholders in planning and design of the DGP for the asset, drive disciplined execution of studies and activities, translate results, and disseminate data and research findings to all relevant internal and external stakeholders.
Provide scientific leadership for best practice in real world evidence/ non-interventional study methodologies, including enabling external scientific advice, ensuring appropriate protocol review committee’s advice sought and incorporated.
Drive innovation and inform ideas and options through effective engagement with external experts, clinical guideline groups, HTA agencies, methodology and policy forums, and by leveraging knowledge of the external policy and decision maker environment to enable more efficient evidence development for the asset across the lifecycle (e.g. discovery, launching and life cycle management assets).
Integrate excellent understanding of the evolving global health technology assessment bodies, clinical guidelines groups, policy decision makers and payer environment, including recommendation, reimbursement, pricing, and access in relevant therapy area.
Lead discussions with key stakeholders on prioritization of data generation in order to meet business and customer needs.
Deliver the materials to inform internal governance decision making (e.g. Medical Review Board, etc).
Facilitate alignment and partnership to enable more effective interactions within the complex stakeholder matrix, e.g. clinical, commercial, market access, medical affairs functions, priority market LOCs as well as external third-party suppliers.
Represent GSK in external collaborations, engagement and scientific evidence requirements with scientific partners, reimbursement bodies and other decision makers.
Drive quality and compliance through team to ensure trust for the evidence that is delivered.
Drive discipline in performance reporting and ensure studies are delivered according to plan and within budget.